Has Neuro Max been evaluated by ConsumerLab, FDA, or FTC for safety or false claims?
Executive summary
Available reporting in the provided documents does not show that a product named “Neuro Max” (as promoted as a brain-health supplement) has been formally evaluated by ConsumerLab, the U.S. Food and Drug Administration (FDA), or the Federal Trade Commission (FTC) for safety or for making false claims; the product label itself reportedly states it “has not been evaluated by the FDA” [1]. The material supplied includes FTC and ConsumerLab records about other supplements and disputes, and a Drugs.com entry for a different “NeuroMAX” formulation (methyl salicylate), but no direct ConsumerLab, FDA, or FTC finding specifically assessing the marketing claims or safety profile of the supplement-brand “Neuro Max” in the corpus provided [2] [3] [4] [5].
1. What the product label and consumer-answers say about FDA evaluation
A user-facing report captured in an online Q&A states that the NeuroMax supplement bottle itself carries the common disclaimer that the product “has not been evaluated by the Food and Drug Administration,” a phrase that appears on many dietary supplements and indicates the manufacturer has not submitted claims to the FDA for pre-market approval [1]. That statement is a primary-source indication from packaging or marketing copy—not an agency finding—so it documents the product’s own claim about FDA non-evaluation rather than an independent regulatory determination [1].
2. ConsumerLab: transparency about testing but no specific Neuro Max test in supplied documents
The supplied ConsumerLab-related material shows the organization actively tests supplements and publicizes results and recalls, and it has reported on FTC actions against other companies while also facing scrutiny from industry groups over disclosure and business practices [6] [4] [7] [2]. However, within the provided ConsumerLab documents and the FTC correspondence about ConsumerLab, there is no specific ConsumerLab test report or certification referenced for a product called “Neuro Max,” and no ConsumerLab page in the supplied set names that supplement as tested or certified [6] [4] [7].
3. FTC: enforcement history on false claims generally, but no cited action against Neuro Max in these sources
The FTC has a record of taking action against supplement marketers for deceptive health claims (ConsumerLab’s own site highlights FTC actions it has reported on), and the FTC has engaged publicly with ConsumerLab and industry complaints about testing and disclosure practices [6] [8] [3] [2]. The documents provided include FTC staff letters and press-type summaries regarding ConsumerLab and other companies, but they do not contain an FTC enforcement action or complaint explicitly directed at a Neuro Max supplement in the materials supplied here [3] [2] [6].
4. FDA: no documented safety evaluation of this supplement in the supplied set; name confusion risk
The provided sources include a Drugs.com patient-leaflet entry for a product called “NeuroMAX” that appears to be a different marketed drug (methyl salicylate) and an FDA recall database entry that references a “NeuroMax Cartridge” (which are distinct contexts), underscoring the risk of confusing similarly named products; neither of those entries in the supplied set should be read as evidence the FDA has evaluated a dietary-supplement Neuro Max for brain-health claims or safety [5] [9]. The only direct statement about FDA evaluation of the supplement-product in the supplied documents is the product-label claim that it has not been evaluated by the FDA [1].
5. Bottom line, limits of this review, and how to follow up
Based strictly on the provided reporting, there is no documented ConsumerLab test report, FDA safety-evaluation record, or FTC enforcement action aimed specifically at a dietary-supplement marketed as “Neuro Max”; the product label claims non-evaluation by FDA [1], and the other documents show related regulatory activity about supplements broadly and about ConsumerLab’s testing and industry complaints but not this product by name [6] [4] [3] [2]. This analysis is limited to the supplied sources; absence of evidence here is not proof that no such evaluations or actions exist outside this corpus, and direct checks of ConsumerLab’s test database, the FDA’s Enforcement Reports/MedWatch/Safety Reporting Portal, and the FTC’s consumer-protection case database are the appropriate next steps to confirm whether any post‑date or external actions concern Neuro Max [6] [3].